CRISPR-Cas9 corrects sickle cell mutation

Collaborative effort to reduce off-target CRISPR-Cas9 genome editing

08-Aug-2018 - Genome editing using the CRISPR-Cas9 system has tremendous promise for therapeutic correction of genetic errors in human cells. Prior to adoption as a medical therapeutic, safety concerns relating to off-target effects must be minimized to mitigate risks that may arise from the unintended action ...

IDT partners with Illumina

Collabortation to deliver robust multiplexing capabilities and streamline target enrichment methods

29-May-2017 - Integrated DNA Technologies (IDT) announced a broad partnership with Illumina, Inc. to provide improved library preparation multiplexing and target enrichment solutions for the next generation sequencing (NGS) market. The agreement will see IDT and Illumina leveraging their expertise in the ...

Integrated DNA Technologies expands global sales network

Company now selling directly to customers in South Korea

03-Jun-2016 - Integrated DNA Technologies (“IDT”) acquired MBiotech, Inc. (“MBiotech”), headquartered in Seoul, South Korea. MBiotech has been a distributor of IDT products for more than a decade. In its promotion of IDT products, MBiotech has successfully made IDT’s brand well-known throughout South Korea. ...

IDT Opens Molecular Biology R&D Facility in Redwood City

Dr Caifu Chen to lead new product development at California site

30-Apr-2015 - Research and development for Integrated DNA Technologies' (IDT) validated molecular biology products will now be performed in a newly built facility in Redwood City, California. The 8,000 square foot building houses state-of-the-art labs that will allow IDT scientists to maximize the company’s ...

IDT’s San Diego Manufacturing Facility Receives ISO 14001 Certification

27-Apr-2015 - Integrated DNA Technologies (IDT) announces that its San Diego, California, manufacturing facility has attained ISO 14001:2004 certification for its environmental management systems. Now, both of IDT’s US manufacturing sites (Coralville, IA and San Diego, CA) have ISO 14001 certified ...

IDT and Ubiquitome Partner to Develop Mobile Ebola Test

04-Dec-2014 - Integrated DNA Technologies (IDT) and Ubiquitome announced a partnership to develop the Ubiquitome Freedom4 Real-Time RT-PCR Ebola Virus Assay for easy use in the field. This rapid test is designed to be run on Ubiquitome’s hand-held, battery powered real-time PCR device, the Freedom4. Fitting in ...

Integrated DNA Technologies Acquires 1st BASE Oligonucleotide Business in Singapore

10-Feb-2012 - Integrated DNA Technologies (IDT) has acquired the oligonucleotide business of 1st BASE Pte. Ltd. IDT will now offer locally-manufactured oligos to researchers in Singapore and throughout the region from the company’s first synthesis facility in Asia.Dr. Joseph Walder, IDT’s founder and Chief ...

Quanta Biosciences and IDT partner to develop and produce microRNA PCR

23-Mar-2011 - Quanta Biosciences has developed hundreds of assays for quantifying microRNAs, and has entered into a partnership with Integrated DNA Technologies to custom manufacture them.MicroRNAs have been shown to play a key role in cancer as well as many biological processes including neurological and ...

IDT is awarded further funding for gene silencing research

Unique U1 adapters silence RNAi refractory genes

23-Jul-2010 - Integrated DNA Technologies (IDT) recently received a Phase II SIBR grant, which will fund the ongoing ‘Gene Silencing with U1 Adapter Oligonucleotides’ research project. As a new class of synthetic nucleic acids, the U1 adapters are capable of down-regulating the expression of genes of interest ...

IDT signs contract to supply Research Councils UK with custom oligonucleotides

14-Jul-2010 - Integrated DNA Technologies has signed a three year contract with Research Councils UK (RCUK) for the supply of synthetic oligonucleotides. RCUK coordinates the UK’s seven research councils, enhancing the overall impact and effectiveness of the research they fund. As one of the preferred ...